stars 1 stars 2 stars 3

Our vision is to be the most customer-centric CRO on earth. We know that biotech and pharma companies look for ways to accelerate clinical trial execution, so we deliver faster, smarter, scientific and affordable clinical development solutions. Founded in 2001 by Dr. Ibrahim Farr, Pivotal is a full-service CRO headquartered in Madrid, operating in more than 27 countries with some 220 employees. We have built focused specialization across all therapeutic areas, with a strong hub in oncology clinical trials, innovative therapies and early phase clinical trials. As a data-driven CRO, we leverage our near real-time advanced analytics platform to discover insights that anticipate trial risks and predict their impact making us an efficient, agile and resilient partner for Phase I, II, III and IV clinical trials. Our Innovative Organizational Model connects scientific, medical and technological expertise to deliver patient-centric and PI-centric trials that reduce timelines, cut costs and maximize our clients' drug development value.

Pivotal Questions

The Pivotal annual revenue was $25 million in 2026.

Ibrahim Farr is the FOUNDER OF PIVOTAL SL, A REGIONAL FULL SERVICE CRO of Pivotal.

165 people are employed at Pivotal.

The NAICS codes for Pivotal are [541, 5417, 54].

The SIC codes for Pivotal are [873, 87].

Top Pivotal Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users